SMS Pharmaceuticals Limited has informed the Exchange regarding 'Re-schedule of Conference Call for the Investors and Analysts'.

" sms

Pharmaceuticals Limited

Registered & Corporate Office: Plot No. 72, H. No. 8-2-334/3 & 4, Road No.5, Opp. S8 1 Executive Enclave, 8anjara Hills, Hyderabad - 500 034, Telangana, INDIA. Tel: +91-40-2525 9999, Fax: +91-40-25259889 CIN : L24239TG1987PLC008066 Email: info@smspharma.com, www.smspharma.com

To, Listing / Compliance Depa rtment BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai - 400001

Date: 18'" Fe brua ry, 2022

Listing / Compliance Departm ent National Stock Exchange of India Limited Exchange Plaza, 51h Floor, Plot No. C- 1, Block G, Bandra-Kurla Compl ex, Bandra (East), Mumbai- 400051

BSE Code: - 532815

NSE Code: SMSPHARMA

Sub: Re-schedule of Conference Call for the Investors and Analysts Ref: Regulation 30(6) ofSEBI (LODR) Regulations, 2015

Dear Sir/Madam,

With reference to our earlier communication letter dated 11th February, 2022 regarding Conference Call for the Investors and Ana lysts which was scheduled to be on today, 18th February 2022 at 11:00 AM, due to some business exigencies stands cancelled. We regret the inconvenience .caused.

,

.

We will update the same in due course of time.

Kindly take the same on record,

Thanking you.

Yours Faithfully,

...